Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021

被引:1
|
作者
Pickens, Cassandra M. [1 ]
Jones, Christopher M. [2 ]
Guy Jr, Gery P. [1 ]
Govoni, Taryn Dailey [3 ]
Green, Jody L. [3 ]
机构
[1] CDC, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE, Atlanta, GA 30341 USA
[2] CDC, Off Director, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE, Atlanta, GA 30341 USA
[3] Inflexxion, Div Uprise Hlth, 2 Pk Plaza,Suite 1200, Irvine, CA 92614 USA
来源
DRUG AND ALCOHOL DEPENDENCE REPORTS | 2023年 / 7卷
关键词
Cocaine; Methamphetamine; Prescription stimulant nonmedical use; Illicit stimulants; Adults assessed for substance use disorder treatment; METHAMPHETAMINE USE; UNITED-STATES; COCAINE USE; PREVALENCE; HEALTH; DRUG; MEDICATIONS;
D O I
10.1016/j.dadr.2023.100153
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Limited data exist on risk factors for illicit stimulant use, including associations between prescription stimulant use/nonmedical use (NMU) and illicit stimulant use.Methods: We used 2017-2021 data from adults assessed for substance use disorder (SUD) treatment using the National Addictions Vigilance Intervention and Prevention Program Addiction Severity Index-Multimedia Version (R) tool. Multivariable Poisson regression models analyzed associations between past 30-day prescription stimulant use as prescribed or NMU and past 30-day illicit stimulant use. Separate models examined past 30-day illicit stimulant, methamphetamine, and cocaine use. We explored problem severity across seven biopsychosocial domains (e.g., drug, psychiatric, family) by past 30-day prescription stimulant use/NMU and illicit stimulant use.Results: Among 218,981 assessments, 1.8% reported prescription stimulant NMU; 1.6% reported use as pre-scribed. Past 30-day prescription stimulant NMU (vs. no use) was associated with past 30-day illicit stimulant use (adjusted prevalence ratio [aPR] [95% CI]: 2.67 [2.59, 2.75]), methamphetamine use (aPR: 2.81 [2.71, 2.92]), and cocaine use (aPR: 3.53 [3.33, 3.74]). Prescription stimulant use as prescribed (vs. no use) was associated with lower prevalence of past 30-day illicit stimulant use. Assessments reporting prescription stimulant NMU (vs. no use, or use as prescribed) appeared more likely to have moderate-to-extreme problem scores across biopsychosocial domains, indicating greater need for treatment or assistance. Assessments reporting prescription stimulant use as prescribed or NMU frequently reported opioids, alcohol, or other substances as their primary substance problem.Conclusions: Adults using illicit stimulants/nonmedically using prescription stimulants may benefit from care addressing polysubstance use, mental health, social, and recovery support services.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
    Tardelli, Vitor S.
    Bisaga, Adam
    Arcadepani, Felipe B.
    Gerra, Gilberto
    Levin, Frances R.
    Fidalgo, Thiago M.
    PSYCHOPHARMACOLOGY, 2020, 237 (08) : 2233 - 2255
  • [32] Nonmedical Use of Prescription Drugs among Medical Students and the Relationship With Illicit Drug, Tobacco, and Alcohol Use
    Papazisis, Georgios
    Tsakiridis, Ioannis
    Siafis, Spyridon
    SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2018, 12
  • [33] Psychosocial functioning associated with prescription stimulant and opioid misuse versus illicit drug use among college students
    Kerr, David C. R.
    Bae, Harold
    Cole, Veronica T.
    Hussong, Andrea M.
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2023, 71 (05) : 1387 - 1396
  • [34] Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
    Assaf, Ryan D.
    Morris, Meghan D.
    Straus, Elana R.
    Martinez, Priest
    Philbin, Morgan M.
    Kushel, Margot
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [35] The Influence of Uncertainty and Social Support on Information Seeking Concerning Illicit Stimulant Use Among Young Adults
    Morse, Chris R.
    Volkman, Julie E.
    Samter, Wendy
    Trunzo, Joseph
    McClure, Kelly
    Kohn, Carolynn
    Logue, Joanna C.
    HEALTH COMMUNICATION, 2013, 28 (04) : 366 - 377
  • [36] Sex differences in the characteristics of stimulant offenders with a history of substance use disorder treatment
    Kondo, Ayumi
    Shimane, Takuya
    Takahashi, Masaru
    Kobayashi, Michiko
    Otomo, Marie
    Takeshita, Yoshiko
    Matsumoto, Toshihiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (04) : 561 - 569
  • [37] Associations of mental illness and substance use disorders with prescription contraception use among women veterans
    Callegari, Lisa S.
    Zhao, Xinhua
    Nelson, Karin M.
    Lehavot, Keren
    Bradley, Katharine A.
    Borrero, Sonya
    CONTRACEPTION, 2014, 90 (01) : 97 - 103
  • [38] Stimulant use among patients in opioid treatment settings: Provider perspectives
    Breland, Haley
    Larkins, Sherry
    Antonini, Valerie
    Freese, Thomas
    Mcgovern, Mark
    Dunn, Julia
    Rawson, Richard
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 151
  • [39] Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention
    Sanchez, Katherine
    Greer, T. L.
    Walker, R.
    Carmody, T.
    Rethorst, C. D.
    Trivedi, M. H.
    JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE, 2017, 16 (04) : 495 - 510
  • [40] Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
    Vitor S. Tardelli
    Adam Bisaga
    Felipe B. Arcadepani
    Gilberto Gerra
    Frances R. Levin
    Thiago M. Fidalgo
    Psychopharmacology, 2020, 237 : 2233 - 2255